Amarin Corporation plc (AMRN) Financials

AMRN Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 831.7 million 279.6 million
2023-09-30 839.0 million 285.9 million
2023-06-30 860.0 million 290.9 million
2023-03-31 860.2 million 275.4 million

AMRN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -1.2 million 4.6 million
2023-09-30 7.3 million 3.6 million
2023-06-30 7.2 million 1.8 million
2023-03-31 -7.0 million 5.6 million

AMRN Net Income

No data available :(

AMRN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 321.2 million - 8.7 million
2023-09-30 320.7 million - 9.0 million
2023-06-30 312.9 million - 9.5 million
2023-03-31 304.4 million - 9.8 million

AMRN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 408.5 million
2023-09-30 408.4 million
2023-06-30 407.8 million
2023-03-31 406.2 million

AMRN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 510959 5.1 million 21.1 million 22.8 million
2023-09-30 1000 5.1 million 21.4 million 24.1 million
2023-06-30 23000 5.6 million 18.6 million 32.3 million
2023-03-31 23000 5.7 million 27.4 million 32.2 million

AMRN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 75.4 million 30.6 million
2023-09-30 66.1 million 36.2 million
2023-06-30 80.2 million 37.5 million
2023-03-31 86.0 million 38.0 million

AMRN

Price: $0.92

52 week price:
0.65
1.49

Payout Ratio Range:
-2039.66%
-184.62%

Earnings Per Share: -0.15 USD

P/E Ratio: -9.92

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - General

Volume: 2.2 million

Ebitda: -8.2 million

Market Capitalization: 385.3 million

Links: